Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Understanding susceptibility to breast cancer metastasis: the genetic approach.

Shukla A, Alsarraj J, Hunter K.

Breast Cancer Manag. 2014 Mar 1;3(2):165-172.


BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.

Alsarraj J, Faraji F, Geiger TR, Mattaini KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, Xiao Z, Andresson T, Esposito D, Smithers N, Lugo D, Prinjha R, Day A, Crawford NP, Ozato K, Gardner K, Hunter KW.

PLoS One. 2013 Nov 19;8(11):e80746. doi: 10.1371/journal.pone.0080746. eCollection 2013.


Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix.

Alsarraj J, Hunter KW.

Int J Breast Cancer. 2012;2012:670632. doi: 10.1155/2012/670632. Epub 2011 Oct 26.


Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.

Alsarraj J, Walker RC, Webster JD, Geiger TR, Crawford NP, Simpson RM, Ozato K, Hunter KW.

Cancer Res. 2011 Apr 15;71(8):3121-31. doi: 10.1158/0008-5472.CAN-10-4417. Epub 2011 Mar 9.


Gene expression profiles and breast cancer metastasis: a genetic perspective.

Hunter KW, Alsarraj J.

Clin Exp Metastasis. 2009;26(6):497-503. doi: 10.1007/s10585-009-9249-8. Epub 2009 Apr 4. Review.


Mechanisms of metastasis.

Hunter KW, Crawford NP, Alsarraj J.

Breast Cancer Res. 2008;10 Suppl 1:S2. doi: 10.1186/bcr1988. Review.


Bromodomain 4 activation predicts breast cancer survival.

Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW.

Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6380-5. doi: 10.1073/pnas.0710331105. Epub 2008 Apr 21.

Supplemental Content

Loading ...
Support Center